Suministro de medicamento exclusivo de Takeda Farmacéutica España, S.A. para los pacientes de la Gerencia de Atención Sanitaria de Melilla
TED · 605860-2026Award noticeawardedNo deadline given
Buyer
NameGerencia de Atención Sanitaria de Melilla - Instituto Nacional de Gestión Sanitaria
CountryES
Published2026-09-02
Deadline—
Value
Estimated—
Awarded€35,613 · 35,612.92 EUR
WinnerTAKEDA FARMACEUTICA ESPAÑA, S.A.
Who already wins at this buyer
Firms with recorded awards from Gerencia de Atención Sanitaria de Melilla - Instituto Nacional de Gestión Sanitaria in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| NOVARTIS FARMACEUTICA, S.A. | 1 | €1,286,400 | 2026-07-21 |
| JANSSEN CILAG SA | 1 | €445,162 | 2026-08-21 |
| ROCHE FARMA, S.A | 1 | €371,538 | 2026-08-13 |
| GLAXOSMITHKLINE, S.A. | 1 | €275,844 | 2026-08-18 |
| MERCK SHARP & DOHME, S.A. | 1 | €235,868 | 2026-08-14 |
CPV codes
33600000 Medical equipment & pharmaceuticalsDescription
Suministro de medicamento exclusivo de Takeda Farmacéutica España, S.A. para los pacientes de la Gerencia de Atención Sanitaria de Melilla